• Repositorio Institucional Universidad de Pamplona
  • Trabajos de pregrado y especialización
  • Facultad de Ciencias Agrarias
  • Medicina Veterinaria
    • Por favor, use este identificador para citar o enlazar este ítem: http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9579
    Registro completo de metadatos
    Campo DC Valor Lengua/Idioma
    dc.contributor.authorPérez Niño, Yelixa.-
    dc.date.accessioned2025-06-17T16:54:10Z-
    dc.date.available2022-
    dc.date.available2025-06-17T16:54:10Z-
    dc.date.issued2022-
    dc.identifier.citationPérez Niño, Y. (2022). Reporte de caso: Mastocitoma grado bajo en un canino bóxer de 6 años de edad [Trabajo de Grado Pregrado, Universidad de Pamplona]. Repositorio Hulago Universidad de Pamplona. http://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9579es_CO
    dc.identifier.urihttp://repositoriodspace.unipamplona.edu.co/jspui/handle/20.500.12744/9579-
    dc.descriptionEl mastocitoma canino es una de las neoplasias con mayor incidencia en caninos. El comportamiento biológico es difícil de predecir y en cuanto a su presentación clínica son masas de tamaño variable, con zona alopécica o con pelo, eritematosa con o sin ulceración, lo que lleva a ser confundidas con lesiones no neoplásicas. En el presente informe se expondrá un caso clínico de un canino macho de 6 años de edad, con presencia de dos masas en piel, correspondientes a una masa alopécica de siete (7) cm de diámetro ubicada en la parte lateral del miembro anterior derecho (MAD) en la región del antebrazo y otra en la región lumbo sacra. Dentro de los exámenes realizados se encuentran análisis hematológico, química sanguínea, ecografía abdominal, citología e histopatología, cuyos resultados permitieron determinar el tipo de neoplasia y el curso de la enfermedad. El tratamiento consistió en la extirpación quirúrgica de la neoplasia y quimioterapia para evitar recidivas y metástasis a otros órganos. Actualmente la evolución del paciente ha sido favorable y continúa en controles médicos cada cierto tiempo.es_CO
    dc.description.abstractCanine mastocytoma is one of the skin neoplasms with the highest incidence in canines. The biological behavior is difficult to predict and in terms of their clinical presentation they are masses of variable size, with an alopecic or hairy area, erythematous with or without ulceration, which leads to being confused with non-neoplastic lesions. In this report, a clinical case of a 6- year-old male canine will be presented, with the presence of two skin masses, corresponding to an alopecic mass of seven (7) cm in diameter located in the lateral part of the right forelimb (MAD) in the forearm region and another in the lumbosacral region. Among the tests performed are hematological analysis, blood chemistry, abdominal ultrasound, cytology and histopathology, the results of which allowed determining the type of neoplasm and the course of the disease. Treatment consisted of surgical removal of the neoplasm and chemotherapy to prevent recurrence and metastasis to other organs. Currently the evolution of the patient has been favorable and continues in medical check-ups from time to time.es_CO
    dc.format.extent58es_CO
    dc.format.mimetypeapplication/pdfes_CO
    dc.language.isoeses_CO
    dc.publisherUniversidad de Pamplona - Facultad de Ciencias Agrarias.es_CO
    dc.subjectCanino.es_CO
    dc.subjectCirugía.es_CO
    dc.subjectMastocitoma.es_CO
    dc.subjectTumores.es_CO
    dc.subjectQuimioterapia.es_CO
    dc.titleReporte de caso: Mastocitoma grado bajo en un canino bóxer de 6 años de edad.es_CO
    dc.typehttp://purl.org/coar/resource_type/c_7a1fes_CO
    dc.date.accepted2022-
    dc.relation.referencesAlbanese, F. (2017). Canine and Feline Skin Cytology. Springer. https://doi.org/10.1007/978-3- 319-41241-2.es_CO
    dc.relation.referencesBlackwood, L., Murphy, S., Buracco, P., De Vos, J., De Fornel-Thibaud, P., Hirschberger, J y Argyle, D. (2012). European consensus document on mast cell tumours in dogs and cats. Veterinary and Comparative Oncology, 10 (3). https://doi.org/10.1111/j.1476- 5829.2012.00341.x.es_CO
    dc.relation.referencesBostock, D. (1973). The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract, 14 (1), 27-41. https://doi.org/10.1111/j.1748-5827.1973.tb06891.x.es_CO
    dc.relation.referencesCartagena, J. (2011). Oncología veterinaria. En Servet (Ed.), Mastocitoma.es_CO
    dc.relation.referencesCooper, M., Tsai, X y Bennett, P. (2009). Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Veterinary and comparative oncology, 7(3), 196-206. https://doi.org/10.1111/j.1476-5829.2009.00190.x.es_CO
    dc.relation.referencesCowell, R., Tyler, R., Meinkoth, J y Denicola, D. (2009). Diagnóstico citológico y hematológico del perro y gato. En JH Meinkorth, RL Cowell, RD Tyler y RJ Morton (Eds.), Recogida y preparación de muestras (Págs. 1 -19). Elsevier.es_CO
    dc.relation.referencesDavies, D., Wyatt, K., Jardine, J., Robertson, J y Irwin, I. (2004). Vinblastine and Prednisolone as Adjunctive Therapy for Canine Cutaneous Mast Cell Tumors. J Am Anim Hosp Assoc, 40 (2), 124–130. https://doi.org/10.5326/0400124.es_CO
    dc.relation.referencesDickerson, V., Coleman, K., Ogawa, M., Saba, C., Cornell, K., Radlinsky, M y Schmiedt, C. (2015). Outcomes of dogs undergoing limb amputation, owner satisfaction with limb amputation procedures, and owner perceptions regarding postsurgical adaptation: 64 cases (2005–2012). J Am Vet Med Assoc, 247 (7), 782-792. https://doi.org/10.2460/javma.247.7.786.es_CO
    dc.relation.referencesDobson, J., Cohen, S y Gould, S. (2004). Treatment of canine mast cell tumours with prednisolone and radiotherapy. Veterinary and Comparative Oncology, 2(3), 132- 141. https://doi.org/10.1111/j.1476-5810.2004.00048.x.es_CO
    dc.relation.referencesDonnelly, L., Mullin, C., Balko, J., Goldschmidt, M., Krick, E., Hume, C., Brown, D y Sorenmo, K. (2013). Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours. Veterinary and comparative oncology, 13(1), 70-76. https://doi.org/10.1111/vco.12021 .es_CO
    dc.relation.referencesEndicott, M., Charney, S., McKnight, J., Loar, A., Barger, A y Bergman, P. (2007). Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999–2002). Veterinary and Comparative Oncology, 5 (1), 31 -37. https://doi.org/10.1111/j.1476-5829.2006.00115.x.es_CO
    dc.relation.referencesFontes, M. (2018). Mastocitoma canino [Tesis de pregrado]. Universidad de la República. http://dspace.fvet.edu.uy:8080/xmlui/handle/123456789/1378.es_CO
    dc.relation.referencesHayes, A., Adams, V., Smith, K., Maglennon, G y Murphy, S. (2007). Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours. Veterinary and comparative oncology ,5(3), 168-176. https://doi.org/10.1111/j.1476-5829.2007.00135.x.es_CO
    dc.relation.referencesHeredia, R., Perales, R., Chavera, A., Tabacchi, L y Santillán, G. (2015). Frequency and histopathological classification of canine mastocytoma in the casuistry (period 2000-2006) of a histopathology veterinary laboratory in Lima, Peru. Rev Inv Vet Perú, 26 (4), 712-718. http://dx.doi.org/10.15381/rivep.v26i4.11207.es_CO
    dc.relation.referencesHorta, R., Lavalle, G., Costa, M., Moura, L., Marcinowska, A y Araujo, R. (2017). Outcome of adjuvant chemotherapy with lomustine, vinblastine and chlorambucil on management of canine mast cell tumour of high to intermediate risk. Arq. Bras. Med. Vet. Zootec, 69 (6), 1426-1436. https://doi.org/10.1590/1678-4162-9172.es_CO
    dc.relation.referencesHosoya, K., Kisseberth, W., Alvarez, F., Garcia, A., Bearner, G., Stromberg, P y Couto, C. (2009). Adjuvant CCNU (Lomustine) and Prednisone Chemotherapy for Dogs With Incompletely Excised Grade 2 Mast Cell Tumors. J Am Anim Hosp Assoc, 45 (1), 14–18. https://doi.org/10.5326/0450014.es_CO
    dc.relation.referencesJaramillo, M. (2019). Estudio Retrospectivo de Mastocitoma Cutáneo en Perros (Canis lupus familiaris) Diagnosticado por Histopatología en el Período 2014-2018 [Tesis de maestría]. Universidad de cuenca. http://dspace.ucuenca.edu.ec/bitstream/123456789/34685/1/Trabajo%20de%20titulaci%c 3%b3n.pdf.es_CO
    dc.relation.referencesKiupel, M y Camus, M. (2019). Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors. Vet Clin Small Anim, 49 (5), 819-836. https://doi.org/10.1016/j.cvsm.2019.04.002.es_CO
    dc.relation.referencesKiupel, M., Webster, J., Bailey, K., Best, S., DeLay, J., Detrisac, C., Fitzgerald, S., Gamble, D., Ginn, P., Goldschmidt, M., Hendrick, M., Howerth, E., Janovitz, E., Langohr, I., Lenz, S., Lipscomb, T., Miller, M., Misdorp, W., Moroff, S y Miller, R. (2011). Proposal of a 2- Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior. Veterinary Pathology, 48 (1), 147–155. https://doi.org/10.1177/0300985810386469.es_CO
    dc.relation.referencesKiupel, M., Webster, J., Miller, E y Kaneene, J. (2005). Impact of Tumour Depth, Tumour Location and Multiple Synchronous Masses on the Prognosis of Canine Cutaneous Mast Cell Tumours. J. Vet. Med, 52 (6), 280-286. https://doi.org/10.1111/j.1439- 0442.2005.00726.x.es_CO
    dc.relation.referencesKry, L y Boston, S. (2014). Additional Local Therapy with Primary Re-Excision or Radiation Therapy Improves Survival and Local Control After Incomplete or Close Surgical Excision of Mast Cell Tumors in Dogs. Veterinary surgery, 43 (2), 182-189. https://doi.org/10.1111/j.1532-950X.2014.12099.x.es_CO
    dc.relation.referencesMeuten, D. (2017). Tumors in domestic animals. En PF Moore (Ed.), Canine and Feline Histiocytic Diseases (págs. 322-336). https://doi.org/10.1002/9781119181200.ch8.es_CO
    dc.relation.referencesMeuten, D. (2017). Tumors in domestic animals. En M Kiupel (Ed.), Mast Cell Tumors (págs. 176-202). https://doi.org/10.1002/9781119181200.ch6.es_CO
    dc.relation.referencesMir, L., Orlowski, S., Belehradek, J y Paoletti, C. (1991). Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. European Journal of Cancer and Clinical Oncology, 27 (1), 68-72. https://doi.org/10.1016/0277-5379(91)90064-K.es_CO
    dc.relation.referencesMochizuki, H., Motsinger-Reif, A., Bettini, C., Moroff, S y Breen, M. (2016). Association of breed and histopathological grade in canine mast cell tumours. Veterinary and comparative oncology, 15(3), 829–839. https://doi.org/10.1111/vco.12225.es_CO
    dc.relation.referencesMusser, M., Berger, E., Flaherty, H., Fox, L y Johannes, C. (2018). Marked paraneoplastic hypereosinophilia associated with a low-grade, metastatic canine mast cell tumour. Veterinary Record Case Reports, 6.https://doi.org/10.1136/ vetreccr-2017-000563.es_CO
    dc.relation.referencesNardi, A., Horta, R., Fonseca, C., Noleto, F., Menescal, L., Firmo, B., Ruiz, F., Oliveira, K., Lourenco, S., Strefezzi, R., Maciel, C., Rangel, M., Jark, P., Costa, J., Ubukata, R., Batschinsky, K., Sobral, R., Oyafuso, N., Tomoko, A., Crestoni, S y Zaidan, M. (2022). Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells, 11 (618). https://doi.org/ 10.3390/cells11040618.es_CO
    dc.relation.referencesNorthrup, N y Gieger, T. (2010). Cancer Management in Small Animal Practice. En CJ Henry y ML Higginbotham (Eds.), Tumors of the Skin, Subcutis, and Other Soft Tissues (págs. 299-332). https://doi.org/10.1016/B978-1-4160-3183-3.10023-7.es_CO
    dc.relation.referencesNorthrup, N., Howeth, E., Harmon, B., Brown, C., Carmicheal, K., Garcia, A., Latimer, K., Munday, J., Rakich, P., Richey, L., Stedman, N y Gieger, T. (2005). Variation among Pathologists in the Histologic Grading of Canine Cutaneous Mast Cell Tumors with Uniform Use of a Single Grading Reference. Journal of Veterinary Diagnostic, 17 (6), 561-564. https://doi.org/10.1177/104063870501700606.es_CO
    dc.relation.referencesOliveira, T., Campos, M., Lamego, L., Magalhães, D., Menezes, R y Ferreira, D. (2020). Canine and feline cutaneous mast cell tumour: a comprehensive review of treatments and outcomes, Topics in Companion Animal Medicine. https://doi.org/10.1016/j.tcam.2020.100472.es_CO
    dc.relation.referencesOlsen, J., Thomson, M., O’Connell, K y Wyatt, K. (2009). Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs. Veterinary Medicine and science, 4 (3), 237-251. https://doi.org/10.1002/vms3.106.es_CO
    dc.relation.referencesPardo, M. (2013). Sarcoma histiocítico en un canino [Tesis de pregrado]. Corporación universitaria lasallista. http://repository.unilasallista.edu.co/dspace/bitstream/10567/1015/1/SARCOMA%20HIS TIOCITICO%20EN%20UN%20CANINO.pdf.es_CO
    dc.relation.referencesPatnaik, A., Ehler, W y MacEwen, E. (1984). Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs. Veterinary Pathology, 21 (5), 469-474. https://doi.org/10.1177/030098588402100503.es_CO
    dc.relation.referencesPratschke, K., Atherton, M., Sillito, J y Lamm, C. (2013). Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008- 2012). J Am Vet Med Assoc, 243 (10), 1436-1441. https://doi.org/10.2460/javma.243.10.1436.es_CO
    dc.relation.referencesRíos, A. (2008). Mastocitoma canino y felino. Clin. Vet. Peq. Anim, 28 (2), 135-142. https://ddd.uab.cat/pub/clivetpeqani/11307064v28n2/11307064v28n2p135.pdf.es_CO
    dc.relation.referencesRojas, D. (2017). Revisión bibliográfica de mastocitoma en caninos. Universidad de los llanos.https://repositorio.unillanos.edu.co/bitstream/handle/001/424/RUNILLANOS.%20 MV0829/REVISION%20BIBLIOGRAFICA%20DE%20MASTOCITOMA%20EN%20 CANINOS.pdf?sequence=1&isAllowed=y#:~:text=El%20mastocitoma%20es%20una%2 0de,ocasiones%20llega%20a%20ser%20maligno.es_CO
    dc.relation.referencesSelmic, L y Ruple, A. (2020). A systematic rewiew of surgical margins utilized for removal of cutaneous mast cell in dogs. BMC Veterinary Research, 16 (1). https://doi.org/10.1186/s12917-019-2227-8.es_CO
    dc.relation.referencesSimčič, P., Pierini, A y Lubas, G. (2021). Treating Mast Cell Tumors with Electrochemotherapy. Electroporation in Veterinary Oncology Practice, 113-135. https://doi.org/10.1007/978- 3-030-80668-2_4.es_CO
    dc.relation.referencesSiqueira, S., Gallon, K., Dalenogare, C y Cardona, R. (2019). Lipoma canino-relato de caso. Unicruz. https://home.unicruz.edu.br/seminario/anais/anais- 2019/XXIV%20SEMINARIO%20INTERINSTITUCIONAL/Mostra%20de%20Iniciacao %20Cientifica/Ciencias%20Exatas,%20agrarias%20e%20engenharias/RESUMO%20EX PANDIDO/LIPOMA%20CANINO%20%E2%80%93%20RELATO%20DE%20CASO %20%20-%209350.pdf.es_CO
    dc.relation.referencesSpugnini, E y Baldi, A. (2019). Electrochemotherapy in Veterinary Oncology. Veterinary Clinics of North America. Vet Clin Small Anim, 49 (5), 967-979. https://doi.org/10.1016/j.cvsm.2019.04.006.es_CO
    dc.relation.referencesSpugnini, E., Vincenzi, B., Citro, G., Dotsinsky, L., Mudrov, T y Baldi, A. (2011). Evaluation of Cisplatin as an Electrochemotherapy Agent for the Treatment of Incompletely Excised Mast Cell Tumors in Dogs. Journal of Veterinary Internal Medicine, 25 (2), 407-411. https://doi.org/10.1111/j.1939-1676.2011.0678.x.es_CO
    dc.relation.referencesTakeuchi, Y., Fujino, Y., Watanabe, M., Takahashid, M., Nakagawami, T., Takeuchib, A., Bonkobara, M., Kobayashigramo, T., Ohnoun, K., Uchidah, K., Asanoi, K., Nishimurad, R., Nakayamah, H., Sugano, S., Ohashib, Y Tsujimotou, H. (2012). Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: A retrospective cohort study. The Veterinary Journal, 196 (3), 492-498. https://doi.org/10.1016/j.tvjl.2012.11.018.es_CO
    dc.relation.referencesTorres, M., Pino, D., Zamora, Y y Matos, R. (2020). Consideraciones actuales sobre las neoplasias cutáneas en la especie canina. Revista de Salud Animal, 42 (2). http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0253-570X2020000200001.es_CO
    dc.relation.referencesTorres, G y Mocha, P. (2006). Mastocitoma canino: reporte de caso. Revista Orinoquia, 10 (2), 45-51. http://www.redalyc.org/articulo.oa?id=89610206.es_CO
    dc.relation.referencesTozon, N., Lampreht, U., Znidar, K., Sersa, G., Teissie, J y Cemazar, M. (2016). Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats. Journal of Visualized Experiments, (116). https://doi.org/10.3791/54760.es_CO
    dc.relation.referencesVail, D., Thamm, D y Liptak, J. (2019). Small Animal Oncology. En CA Londres, C y DH Thamm (Eds.), Mast Cell Tumors, (págs. 382-403). https://doi.org/10.1016/B978-0-323- 59496-7.00021-9.es_CO
    dc.relation.referencesVicario, P y Naranjo, C. (2018). Factores clínicos y patológicos importantes en el pronóstico del mastocitoma canino. Clin. Vet. Peq. Anim, 38 (4), 235-240. https://www.clinvetpeqanim.com/img/pdf/1534109958.pdf.es_CO
    dc.relation.referencesWebster, J., Yuzbasíyan-Gurkan, V., Thamm, D., Hamilton, E y Kiupel, M. (2008). Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone. BMC Veterinary Research, 4(32). https://doi.org/10.1186/1746-6148-4-32.es_CO
    dc.relation.referencesWebster, J., Yuzbasíyan-Gurkan, V., Miller, R., Kaneene, J y Kiupel, M. (2007). Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication. Veterinary Pathology, 44 (3), 298-308. https://doi.org/10.1354/vp.44-3-298.es_CO
    dc.relation.referencesWillmann, M., Yuzbasíyan-Gurkan, V., Marconato, L., Dacasto, M., Hadzijusufovic, E, Hermine, O., Sadovnik, I., Gamperl, S., Schneeweiss, M., Gleixner, K., Böhm, T., Peter, B., Eisenwort, G., Moriggl, R., Li, Z., Jawhar, M., Sotlar, K., Jensen, E., Sexl, V., Horny, H., Galli, S., Arock, M., Vail, D., Kiupel, M y Valent, P (2021). Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal. Frontiers Veterinary Science, 8. https://doi.org/10.3389/fvets.2021.755258.es_CO
    dc.relation.referencesYodence, A., Wallace, M., Grimes, J., Schmiedt, C. (2022). Dogs undergoing surgical excision of mast cell tumors are not at increased risk of incisional complications. J Am Vet Med Assoc, 260 (1), 88-95. https://doi.org/10.2460/javma.20.09.0488.es_CO
    dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2es_CO
    dc.type.coarversionhttp://purl.org/coar/resource_type/c_2df8fbb1es_CO
    Aparece en las colecciones: Medicina Veterinaria

    Ficheros en este ítem:
    Fichero Descripción Tamaño Formato  
    Pérez_2022_TG.pdfPérez_2022_TG895,62 kBAdobe PDFVisualizar/Abrir
    Mostrar el registro sencillo del ítem


    Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.